Mesenchymal Stem Cell Secretome for Ischemic Stroke: CD31 and VEGF Expression
DOI:
https://doi.org/10.21123/bsj.2024.11813Keywords:
CD31, VEGF, Secretome, MSC, Ischemic Stroke., CD31, VEGF, Secretome, MSC, Ischemic Stroke.Abstract
Standard treatments for ischemic stroke are intravenous thrombolysis and endovascular recanalization. In the acute phase (<4.5 hours) only 3.2% to 5.2% of ischemic stroke patients are eligible for intravenous thrombolysis. Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into different types of cells that produce potential regenerative therapeutics in stroke patients. MSCs will secrete secretomes that contain growth factors, chemokines, cytokines, metabolites and bioactive lipids. Secretome promote production of CD31 and Vascular Endothelial Growth Factor (VEGF). Neurogenesis and angiogenesis effect from CD31 and VEGF cause brain cell regeneration and neurological improvement. This study analyzes the effect of 150 ml SH-MSCs injection toward CD31 and VEGF expression in rats with ischemic stroke. The method used was laboratory true experimental post-test with only control group design and sample was taken with consecutive sampling. It uses 18 Rattus norvegicus and divided into sham, control and P1 (MCAO + 150 ul secretome) groups. Control and P1 group were made in stroke condition with Middle Cerebral Artery Occlusion methods by clamping Common Carotid Artery. Modified Neurological Severity Score (mNSS) used to measure neurological function improvement. Mean value of VEGF and CD31 expression in P1 higher than control group and mNSS in P1 lower than control group. Through the increases of VEGF and CD31 expressions, SH-MSCs can drive cell proliferation, neuron cell survival, angiogenesis, neurogenesis and blood-brain-barrier integrity recovery in the rats’ brains, so it improves clinical outcomes and neurological function in rats with ischemic stroke.
References
Khaku AS, Tadi P. Cerebrovascular Disease. StatPearls Publishing. 2024 Jan.
Herpich F, Rincon F. Management of Acute Ischemic Stroke. Crit Care Med. 2020 Nov; 48(11): 1654–1663. https://doi.org/10.1097/CCM.0000000000004597
Yaqubi S, Karimian M. Stem Cell Therapy as a Promising Approach for Ischemic Stroke Treatment. Curr Res Pharmacol Drug Discov. 2024; 100183. https://doi.org/10.1016/j.crphar.2024.100183
Yong KW, Choi JR, Mohammadi M, Mitha AP, Sanati NA, Sen A, et al. Mesenchymal Stem Cell Therapy for Ischemic Tissues. Stem Cells Int. 2018 Oct; 2018: 8179075: 1–11. https://doi.org/10.1155/2018/8179075
Mohammad MH, Al-Shammari AM, Abdulla RH, Ahmed AA, Khaled A. Differentiation of Adipose-Derived Mesenchymal Stem Cells into Neuron-Like Cells induced by using β-mercaptoethanol. Baghdad Sci J. 2020 March; 17(1): 235-243. https://dx.doi.org/10.21123/bsj.2020.17.1(Suppl.).0235
Mohammad MH, Almzaien AK, Al-Joubory AA, Al-Shammari AM, Ahmed AA, Shaker HK, et al. In vitro isolation and expansion of neural stem cells NSCs. Baghdad Sci J. 2023 Nov; 20(3): 787-796. https://dx.doi.org/10.21123/bsj.2022.7280
He J, Liu J, Huang Y, Tang X, Xiao H, Hu Z. Oxidative Stress, Inflammation and Autophagy: Potential Targets of Mesenchymal Stem Cells-Based Therapies in Ischemic Stroke. Front Neurosci. 2021 Feb; 15: 641157. https://doi.org/10.3389/fnins.2021.641157
Ahangar P, Mills SJ, Cowin AJ. Mesenchymal Stem Cell Secretome as an Emerging Cell-Free Alternative for Improving Wound Repair. Int J Mol Sci. 2020 Sep; 21(19): 7038. https://doi.org/10.3390/ijms21197038
Műzes G, Sipos F. Mesenchymal Stem Cell-Derived Secretome: A Potential Therapeutic Option for Autoimmune and Immune-Mediated Inflammatory Diseases. Cells. 2022 Aug; 11(15): 2300. https://doi.org/10.3390/cells11152300
Gwam C, Mohammed N, Ma X. Stem Cell Secretome, Regeneration, and Clinical Translation: A Narrative Review. Ann Transl Med. 2021 Jan; 9(1): 70. https://doi.org/10.21037/atm-20-5030
Rajendra SA, Chen DS, Ferrara N. VEGF in Signalling and Disease: Beyond Discovery and Development. Cell. 2019 Mar; 176(6): 1248-12664. https://doi.org/10.1016/j.cell.2019.01.021
Moon S, Chang MS, Koh SH. Repair Mechanism of Neurovascular Unit after Ischemic Stroke with a Focus on VEGF. Int J Mol Sci. 2021 Jun; 22(16): 8543. https://doi.org/10.3390/ijms22168543
Li Y, Dong Y, Ran Y, Zhang Y, Wu B, Xie J. Three-dimensional cultured mesenchymal stem cells enhance repair of ischemic stroke through inhibition of microglia. Stem Cell Res Ther. 2021 Jun; 12(1): 358. https://doi.org/10.1186/s13287-021-02416-4
Navarro KL, Huss M, Smith JC, Sharp P, Marx JO, Pacharinsak C. Mouse Anesthesia: The Art and Science. ILAR J. 2021; 62(1-2): 238-273. https://doi.org/10.1093/ilar/ilab016
Sari MI, Jusuf NK, Munir D, Putra A, Bisri T, Ilyas S, et al. The Role of Mesenchymal Stem Cell Secretome in the Inflammatory Mediators and the Survival Rate of Rat Model of Sepsis. Biomedicines. 2023 Aug; 11(8): 2325-2339. https://doi.org/10.3390/biomedicines11082325
Albada ME, Sarvaas GJ, Koster J, Houwertjes MC, Berger RMF, Schoemaker RG. Effects of Erythropoietin on Advanced Pulmonary Vascular Remodelling. Eur Respir J. 2008; 31: 126-134. https://doi.org/10.1183/09031936.00035607
Alam JJ, Krakovsky M, Germann U, Levy A. Continuous Administration of a P38α Inhibitor during The Subacute Phase After Transient Ischemia-Induced Stroke in the Rat Promotes Dose-Dependent Functional Recovery Accompanied by Increase in Brain BDNF Protein Level. PLOS ONE. 2020; 15(12): e0233073. https://doi.org/10.1371/journal.pone.0233073
Taei AA, Nasoohi S, hassanzadeh G. Enhancement of Angiogenesis and Neurogenesis by Cerebroventricular Injection of Secretome from Human Embryonic Stem-Cell-Derived Mesenchymal Stem Cells in Ischemic Stroke Model. Biomed Pharmacother. 2021 Aug; 140: 111709. https://doi.org/10.1016/j.biopha.2021.111709
Castro SB, Sousa JA, Bras A, Cecilia C, Rodrigues B, Almendra L. Pathophysiology of Blood-Brain-Barrier Permeability Throughout the Different Stages of Ischemic Stroke snd Its Implication on Hemorrhagic Transformation and Recovery. Front Neurol. 2020 Dec; 11: 594672. https://doi.org/10.3389/fneur.2020.594672
Jingli Y, Jing W, Saeed Y. Ischemic Brain Stroke and Mesenchymal Stem cells: An Overview of Molecular mechanism and therapeutic Potential. Stem Cells Int. 2022 May; 2022: 5930244; 15. Available from: doi: https://doi.org/10.1155/2022/5930244
Shen XY. Activation and Role of Astrocytes in Ischemic Stroke. Front Cell Neurosci. 2020 Nov; 15: 755955. https://doi.org/10.3389/fncel.2021.755955
Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine. Int J Mol Sci. 2017 Sep; 18(9): 1852. https://doi.org/10.3390/ijms18091852
Chen S, Saeed AFUH, Liu Q, Jiang Q, Xu H, Xiao GG, et al. Macrophages in Immunoregulation and Therapeutics. Signal Transduct Target Ther. 2023 May; 8(1): 207-242. https://doi.org/10.1038/s41392-023-01452-1
Sazli BI, Lindarto D, Hasan R, Putra A, Pranoto A, Sembiring RJ, et al. Secretome of Hypoxia-Preconditioned Mesenchymal Stem Cells Enhance Angiogenesis in Diabetic Rats with Peripheral Artery Disease. Med Arch. 2023 Apr; 77(2): 90-96. https://doi.org/10.5455%2Fmedarh.2023.77.90-96
Taei AA, Nasoohi S, hassanzade G. Enhancement of Angiogenesis and Neurogenesis by Cerebroventricular Injection of Secretome from Human Embryonic Stem-Cell-Derived Mesenchymal Stem Cells in Ischemic Stroke Model. Biomed Pharmacother. 2021 Aug; 140: 111709. https:/doi.org/10.1016/j.biopha.2021.111709
Yusoff FM, Nakashima A, Kawano KI, Kajikawa M, Kishimoto S, Maruhashi T, et al. Implantation of Hypoxia-Induced Mesenchymal Stem Cell Advances Therapeutic Angiogenesis. Stem Cells Int. 2022 Mar; 2022: 6795274. https://doi.org/10.1155/2022/6795274
Foo JB, Looi QH, Chong PP, Hassan NH, Yeo GEC, Ng CY, et al. Comparing the Therapeutic Potential of Stem Cells and their Secretory Products in Regenerative Medicine. Stem Cells Int. 2021 Aug; 2021: 2616807. https://doi.org/10.1155/2021/2616807
Kanazawa M, Takahashi T, Ishikawa M. Angiogenesis in The Ischemic Core: A Potential Treatment Target? J Cereb Blood Flow Metab. 2019 May; 39(5): 753-769. https://doi.org/10.1177/0271678X19834158
Zhu H. Inflammation-Mediated Angiogenesis in Ischemic Stroke. Front Cell Neurosci. 2021; 15: 652647. https://doi.org/10.3389/fncel.2021.652647
Whelan S. What is Angiogenesis. Technology Networks Cancer Research. 2022 July.
Gong P, Zhang W, He Y, Wang J, Li S, Chen S, et al. Classification and Characteristics of Mesenchymal Stem Cells and Its Potential Therapeutic Mechanism and Applications Against Ischemic Stroke. Stem Cells Int. 2021 Nov; 2021: 2602871. https://doi.org/10.1155/2021/2602871
Ruan J, Yao Y. Behavioral Test in Rodent models of Stroke. Brain Hemorrhages. 2020 Dec; 1(4): 171-184. https://doi.org/10.1016/j.hest.2020.09.001
Tobin MK, Stephen TKL, Lopez KL. Activated Mesenchymal Stem Cells Induce Recovery Following Stroke Via Regulation of Inflammation and Oligodendrogenesis. J Am Heart Assoc. 2020 Apr; 9(7): e013583. https://doi.org/10.1161/JAHA.119.013583
Ye YC, Chang ZH, Wang P, Wang YW, Liang J, Chen C, et al. Infarct-preconditioning Exosomes of Umbilical Cord Mesenchymal Stem Cells Promoted Vascular Remodeling and Neurological Recovery after Stroke in Rats. Stem Cells Res Ther. 2022 Jul; 13(1): 378-393. https://doi.org/10.1186/s13287-022-03083-9
Downloads
Issue
Section
License
Copyright (c) 2024 dr. Sisca Silvana, M.Ked(Ped), Sp.A(K) , Iskandar Japardi, Muhammad Rusda, Rini Savitri Daulay, Agung Putra, Irawan Mangunatmadja, Dewi Masyithah Darlan, Sri Sofyani, Yana Andreas
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
